我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

肺炎衣原体感染在冠心病发生与发展中的作用(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2001年第3期
页码:
234-236
栏目:
综述
出版日期:
2001-05-01

文章信息/Info

Title:
-
作者:
徐红新 综述;  李建军;  李庚山 审校
湖北医科大学附属一院心内科, 湖北武汉 430060
Author(s):
-
关键词:
动脉粥样硬化;  冠状动脉疾病;  肺炎衣原体
Keywords:
-
分类号:
R541.4;R374
DOI:
-
文献标识码:
A
摘要:
许多流行病学研究及大量血清学证据均提示肺炎衣原体与冠心病之间有强的相关性。通过透射电镜、ICC及PCR等技术,在动脉粥样硬化病变组织中检测出肺炎衣原体又为这一相关性提供了有力的客观依据,动物模型的建立及对冠心病患者进行二级预防的一些临床研究也取得了令人鼓舞的成果。
Abstract:
-

参考文献/References

[1] Danesh J, Collins R,Peto R. Chronic infections and coronary heart disease:is there a link[J].Lancet,1997,350:430-436.

[2]Sessa R. Chlamydia pneumoniae infection and atherosclerosis coronary disease[J].Am Heart J , 1999,137(6):116-119.

[3] Gupta S,Camm AJ. Chlamydia pneumoniae and coronary heart disease:coincidence association or casusation? [J].Br Med J,1997,314:1778-1779.

[4] Zhou YF,Csako G,Grayston JT,et al. Lack of association of restenosis following coronary angioplasty with elevated C-Reactive protein levels or seropositivity to chlamydia pneumoniae[J].Am J Cardiol,1999,84:595-597.

[5] Abdelmouttaleb I,Danchin N,Ilardo C,et al. C-Reactive protein and coronary artery disease:Additional evidence of the implication of an inflammatory process in acute coronary syndromes [J].Am Heart J,1999,137:347-351.

[6]Mass M,Krause E,Kruger S,et al. Coronary arteries harbour viable chlamydia pneumoniae. Fourth international symposium on modern concepts in endocarditis and cardiovascular infections [abstract] [J].Yverdon-Les-Baines,Switzerland, 1997. (abstract 101).

[7] Jackson LA,Campbell LA,Schmidt RA,et al. Specifity of detection chlamydia pneumoniae in cardiovascular atheroma[J].Am J Pathol,1997,150:1785-1790.

[8] Davidson M,Kuo CC,Middaugh JP,et al. Confirmed previous infection with chlamydia pneumoniae(TWAR) and its presence in early coromas atherosclerosis[J].Circulation,1998,98:628-633.

[9] Knoebel E,Vijayagopal P,Figureroa JE,et al.In vitroinfection of smooth muscle cells by chlamydia pneumoniae[J].Infect Immun,1997,65:503-506.

[10]Muhlestein E,Anderson JL,Hammond EH,et al. Infection with chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with Azithromycin prevents it in a rabbit model[J].Circulation,1998,97:633-636.

[11]Fong AW,Chiu B,Viira E,et al. Rabbit models for chlamydia pneumoniae infection[J].J Clin Microbiol,1997,35:48-52.

[12]Laitinen K,Laurila A,Phala L,et al. Chamydia pneumoniae induces inflammatory changes in the aortas of rabbits[J].Infect Immun,1997,65:4832-4835.

[13] Gupta S, Leatham EW, Carrigton D,et al. The effect of azithromycin in post myocardial infarction patients with elevated chlamydia pneumoniae antibody titers (Abstract) [J].J Am Coll Cardiol,1997,29(2,Suppl):209A.

[14]Gupta S,Leatham EW,Carrington D,et al. Elevated chlamydia pneumoniae antibodies. Cardiovascular events and azithromycin in male survivors of myocardial infarction [J].Circulation, 1997,96:404-407.

[15]Gurfinkel E,CRP Bozovich G,Beckt E,et al. Treatment with the antibiotic roxithromycin in patients with non-Q-Wave coronary syndromes[J].Eur Heart J,1999,20:121-127.

[16 ] Anderson JL. Randomized secondary prevention trial of azithromycion in patients with coronary artery diease and serological evidence for chlamydia pneumoniae infection with chlamydia. (ACADEMIC)study[J].Circulation,1999,99(12): 1540.

备注/Memo

备注/Memo:
收稿日期：2000-03-21.
更新日期/Last Update: 2001-05-01